Camlin Fine Sciences Ltd

Camlin Fine Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Camlin Fine Sciences Ltd

₹ 302 0.60%
13 Jun - close price
camlinfs.com BSE: 532834 NSE: CAMLINFINE
About

Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.

Key Points

Business Verticals

Website BSE NSE
  • Market Cap ₹ 5,677 Cr.
  • Current Price ₹ 302
  • High / Low ₹ 316 / 93.4
  • Stock P/E 309
  • Book Value ₹ 45.9
  • Dividend Yield 0.00 %
  • ROCE 3.04 %
  • ROE 2.33 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Debtor days have improved from 215 to 171 days.
  • Promoter holding has increased by 1.08% over last quarter.

Cons

  • Stock is trading at 6.58 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 8.86% over past five years.
  • Company has a low return on equity of 0.82% over last 3 years.
  • Company has high debtors of 171 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
201 155 243 173 218 161 206 186 220 182 227 205 273
170 140 201 145 184 136 185 180 246 175 213 189 239
Operating Profit 31 15 42 28 34 25 21 6 -26 7 14 16 33
OPM % 16% 10% 17% 16% 16% 16% 10% 3% -12% 4% 6% 8% 12%
8 13 12 11 1 6 6 2 4 2 -93 7 9
Interest 10 16 16 12 13 12 15 13 14 14 18 17 17
Depreciation 7 7 7 8 11 12 12 12 13 13 13 13 13
Profit before tax 22 5 31 19 11 7 -1 -18 -49 -18 -111 -7 12
Tax % 29% -2% 39% 18% 32% 20% 181% -34% -9% -22% -34% -22% -31%
16 5 19 16 8 6 -1 -12 -44 -14 -73 -6 16
EPS in Rs 0.89 0.30 1.06 0.90 0.44 0.31 -0.08 -0.62 -2.35 -0.73 -3.86 -0.30 0.83
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
374 431 412 325 403 548 580 600 686 789 773 886
315 370 344 300 395 515 517 534 605 656 738 816
Operating Profit 60 61 68 24 8 33 63 66 80 133 35 71
OPM % 16% 14% 16% 8% 2% 6% 11% 11% 12% 17% 5% 8%
1 2 -1 13 9 14 21 5 19 29 17 -75
Interest 22 21 22 26 26 23 31 36 36 62 62 66
Depreciation 9 10 10 12 9 9 11 19 27 33 49 53
Profit before tax 29 32 35 0 -18 14 41 15 36 67 -60 -123
Tax % 35% 19% 26% 809% -22% 24% 26% 45% 28% 29% -14% -38%
19 26 26 -1 -14 11 31 8 26 48 -51 -76
EPS in Rs 1.79 2.40 2.37 -0.07 -1.04 0.79 2.26 0.58 1.47 2.70 -2.73 -4.06
Dividend Payout % 17% 17% 17% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: 9%
3 Years: 9%
TTM: 15%
Compounded Profit Growth
10 Years: -3%
5 Years: -11%
3 Years: -11%
TTM: 138%
Stock Price CAGR
10 Years: 12%
5 Years: 49%
3 Years: 41%
1 Year: 178%
Return on Equity
10 Years: 3%
5 Years: 2%
3 Years: 1%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 9 10 10 10 12 12 12 13 16 16 17 19
Reserves 67 88 111 165 319 335 365 452 577 626 699 843
132 135 159 242 218 313 340 378 461 617 511 458
79 113 102 56 128 120 175 224 293 335 345 309
Total Liabilities 287 346 382 474 678 781 891 1,067 1,346 1,594 1,572 1,629
48 63 89 79 72 82 96 294 304 583 577 569
CWIP 2 0 1 14 20 68 198 18 207 28 31 9
Investments 4 5 7 44 148 69 74 74 82 82 80 102
234 278 285 337 438 562 523 681 753 901 884 949
Total Assets 287 346 382 474 678 781 891 1,067 1,346 1,594 1,572 1,629

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
13 26 51 -30 -5 -45 74 26 47 19 82 22
-7 -23 -49 -31 -116 -3 -66 -88 -172 -115 -52 -88
-3 -5 -1 61 120 65 -26 80 129 78 -34 101
Net Cash Flow 3 -1 0 0 -1 17 -18 18 3 -18 -4 35

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 89 105 87 148 192 174 204 224 235 243 232 171
Inventory Days 75 118 176 209 138 98 91 127 132 252 210 200
Days Payable 93 123 119 65 137 95 125 186 196 248 234 203
Cash Conversion Cycle 72 100 144 291 192 177 170 165 171 246 208 167
Working Capital Days 123 118 132 260 245 210 206 220 205 255 242 223
ROCE % 28% 24% 24% 7% 2% 6% 11% 7% 8% 11% 0% 3%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
17.65% 17.64% 17.64% 17.64% 16.52% 48.03% 48.03% 48.04% 48.03% 48.03% 48.03% 49.09%
10.74% 11.32% 10.94% 10.18% 10.11% 1.61% 0.99% 1.69% 1.01% 0.81% 0.76% 1.47%
14.20% 13.53% 12.53% 12.32% 9.31% 3.89% 3.75% 4.55% 4.88% 4.23% 3.38% 3.83%
0.00% 0.00% 0.00% 0.03% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
57.42% 57.52% 58.88% 59.82% 64.01% 46.46% 47.22% 45.73% 46.07% 46.93% 47.83% 45.61%
No. of Shareholders 57,83557,90454,19752,92152,27857,09862,09858,16562,68767,75061,89358,111

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls